TNFSF11 and AL amyloidosis: The increase in RANKL levels characterizes almost all bone-associated cancers such as multiple myeloma and metastases derived from primary tumors which spread to the skeleton, i.e., carcinomas of the prostate, breast, lungs, thyroid, bladder, and kidneys as well as melanoma (89).